bioRxiv Science⌕ Search

Biology subjects

KIZILEL, S.

Publications and source records attributed to KIZILEL, S..

4 recordsLinked to original sources

Taguchi/Machine Learning Hybrid Framework for Optimization of Particulate Drug Delivery Systems

Optimizing particulate drug carrier systems requires balancing multiple formulation parameters to achieve target physicochemical properties while minimizing experimental burden. Here, we implement a hybrid optimization framework integrating a Taguchi orthogonal array (OA) design with statistical modeling and machine learning (ML)-based interpretability, using doxorubicin-loaded chitosan microspheres (DOX-CS MSs). Microspheres were synthesized via a water-in-oil emulsion crosslinking method and characterized by FTIR, XRD, and FESEM to confirm chemical structure, crystallinity, and spherical morphology. The optimization targeted a particle size of 5-7 {micro}m and encapsulation efficiency (EE) >90%. An initial L Taguchi OA design efficiently narrowed the formulation space by varying chitosan concentration (1-3% w/v), glutaraldehyde concentration (1.5-5% v/v), and crosslinking time (3-5 h), yielding nine core formulations. Pearson/Spearman correlation, second-order polynomial regression (Poly{superscript 2}), and Gradient Boosting Machine (GBM) models quantified parameter influences and predicted performance. SHapley Additive exPlanations (SHAP) identified chitosan concentration as the primary determinant of both size and EE, with glutaraldehyde content exerting secondary, synergistic effects. Poly{superscript 2} response-surface modeling achieved high predictive accuracy (R{superscript 2} = 0.983 for size; R{superscript 2} = 0.986 for EE) and yielded explicit regression equations for real-time formulation targeting. This hybrid Taguchi-ML approach enables rapid factor prioritization, reveals nonlinear interactions overlooked by conventional Taguchi analysis, and offers transparent ML interpretability. Beyond chitosan-based carriers, it provides a generalizable, scalable route to rational formulation design in complex particulate systems for targeted biomedical applications.

bioengineering↗

Single-gene knockout of RNLS or HIVEP2 are insufficient to protect β-cell spheroids from allo- and xeno-rejection

Type 1 diabetes can be cured by {beta}-cell replacement in principle, yet recurrent autoimmunity and transplantation barriers rapidly destroy implanted cells. Genome-wide CRISPR screening by Cai et al. highlighted RNLS and HIVEP2 as candidate genes, but their value outside an autoimmune setting is unknown. Here, it was evaluated whether single-gene knockout of RNLS or HIVEP2 could similarly protect {beta}-cell grafts against allo- and xenogeneic rejection. Murine {beta}-TC-6 and human EndoC-{beta}H1 cell lines were genetically edited using CRISPR-Cas9 to knockout RNLS or HIVEP2, and editing efficiencies were confirmed via T7 endonuclease I assay and TIDE analysis. Functional characterization indicated that RNLS deletion modestly impaired glucose-stimulated insulin secretion in murine cells, whereas HIVEP2 deletion showed no functional alterations in either cell line. For in vivo assessment, genetically edited {beta}-cell spheroids were subcutaneously transplanted into CD-1 mice to model allo- (murine {beta}-cells) and xenogeneic (human {beta}-cells) rejection scenarios. Bioluminescence imaging revealed no protective effects of RNLS or HIVEP2 deletion, with grafts from both knockout groups displaying identical rejection kinetics compared to controls. These findings indicate that single-gene deletions of RNLS or HIVEP2 are insufficient for conferring meaningful protection against allo- or xenorejection, highlighting the necessity for combinatorial genome editing strategies or complementary biomaterial-based immunomodulation to achieve effective and sustained {beta}-cell graft survival.

bioengineering↗

Effect of Photoinitiation Process on Photo-Crosslinking of Gelatin Methacryloyl Hydrogel Networks

Gelatin methacryloyl (GelMA) has emerged as a widely utilized biomaterial in tissue engineering due to its tunable mechanical properties, cell-adhesive motifs, and photo-crosslinkability. However, the physicochemical characteristics and biomedical utility of GelMA hydrogels are greatly influenced by the choice and concentration of photoinitiating systems. Despite the increasing acceptance of visible-light and UV-sensitive initiators, a systematic comparative evaluation of their impact on GelMA hydrogel properties remains limited. In this study, we present the first systematic investigation of how individual photoinitiators, Eosin Y (EY), Lithium Phenyl-2,4,6-trimethylbenzoylphosphinate (LAP), Ruthenium (II) trisbipyridyl chloride ([RuII(bpy)3]2+) (Ru), affect the viscoelastic properties, swelling behavior, degradation kinetics, and cytocompatibility of 5% and 10% (w/v) GelMA hydrogels. By varying photoinitiator concentrations ([EY]: 0.005-0.1 mM, [LAP]: 0.01-0.5% (w/v), [Ru]: 0.02-1 mM) and utilizing consistent light intensity (10 mW/cm2 at system-specific wavelengths), we identified critical thresholds and plateau behaviors that distinctly influenced the stiffness and integrity of the hydrogels. Our findings revealed that each photoinitiating system exhibits unique advantages and trade-offs. LAP and Ru systems facilitated rapid gelation with easier utilization and were associated with higher swelling and accelerated degradation profiles--features particularly advantageous for applications such as 3D bioprinting and in situ injectable hydrogel systems. However, their atypical behaviors at certain concentrations and light exposure durations highlight the necessity for precise control and further mechanistic exploration. In contrast, EY-mediated hydrogels offered superior stiffness and minimal swelling at optimal concentrations, favoring applications that demand long-term mechanical stability, at the cost of a more complex cross-linking mechanism. Notably, by correlating mechanical and degradation behaviors with NIH-3T3 fibroblast viability, we also assessed biocompatibility window for each concentration of the systems, linking biomaterial performance with biomedical applicability. Overall, our study underlines the importance of tailoring photoinitiator selection and concentration to specific application needs, striking a balance between gelation kinetics, mechanical integrity, degradation behavior, and cytocompatibility. These insights provide a foundational framework for engineering GelMA-based hydrogels paving the way for reproducible, efficient, targeted biomedical applications. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=114 SRC="FIGDIR/small/648118v1_ufig1.gif" ALT="Figure 1"> View larger version (26K): org.highwire.dtl.DTLVardef@1286f72org.highwire.dtl.DTLVardef@1aca5f6org.highwire.dtl.DTLVardef@1c3bc63org.highwire.dtl.DTLVardef@1850c97_HPS_FORMAT_FIGEXP M_FIG C_FIG

bioengineering↗

A unique and biocompatible approach for corneal collagen crosslinking in vivo

Corneal crosslinking (CXL) is a widely applied technique to halt the progression of ectatic diseases by increasing the thickness and mechanical stiffness of the cornea. This study investigated the biocompatibility and efficiency of a novel CXL procedure using ruthenium and blue light in rat corneas and evaluated factors important for clinical application. To perform the CXL procedure, the corneal epithelium of rats was removed under anesthesia, followed by the application of a solution containing ruthenium and sodium persulfate (SPS). The corneas were then exposed to blue light at 430 nm at 3 mW/cm2 for 5 minutes. Rat corneas were examined and evaluated for corneal opacity, corneal and limbal neovascularization, and corneal epithelial regeneration at days 0, 1, 3, 6, 8, and 14. On day 28, the corneas were isolated for subsequent tissue follow-up and analysis. CXL with ruthenium and blue light showed rapid epithelial healing, with 100% regeneration of the corneal epithelium and no corneal opacity by day 6. The ruthenium group also exhibited significantly reduced corneal (p<0.01) and limbal neovascularization (p<0.001). Histological analysis revealed no signs of cellular damage or apoptosis, which further confirms the biocompatibility and nontoxicity of our method. Confocal and scanning electron microscopy (SEM) images showed a greater density of collagen fibrils, indicating efficient crosslinking and enhanced structural integrity. This study confirmed the in vivo safety, biocompatibility, and functionality of ruthenium and blue light CXL. This method can prevent toxicity caused by UV-A light and can be a rapid alternative treatment to standard crosslinking procedures. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=102 SRC="FIGDIR/small/585574v1_ufig1.gif" ALT="Figure 1"> View larger version (25K): org.highwire.dtl.DTLVardef@c05147org.highwire.dtl.DTLVardef@18244borg.highwire.dtl.DTLVardef@f6e30eorg.highwire.dtl.DTLVardef@b4ec3a_HPS_FORMAT_FIGEXP M_FIG C_FIG

bioengineering↗